Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending

Commenting on a recently published article on sicca syndrome linked to immune checkpoint inhibitor therapy, this letter to the editor shares another viewpoint on the management of this immune‐related adverse event.

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Ortiz Brugués, Ariadna, Sibaud, Vincent, Herbault‐Barrés, Beatrice, Betrian, Sarah, Korakis, Iphigenie, De Bataille, Caroline, Gomez‐Roca, Carlos, Epstein, Joel, Vigarios, Emmanuelle
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2019
Témata:
Letters to the Editor
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011671/
https://ncbi.nlm.nih.gov/pubmed/32043780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0467
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky